
Sarispas M Oral Suspension
Marketer
Senate Laboratories
Salt Composition
Mefenamic Acid (50mg/5ml) + Paracetamol (125mg/5ml)
Overview Sarispas M Oral Suspension
PediaTemp Oral Suspension combines two active components, both categorized as non-steroidal anti-inflammatory drugs (NSAIDs). This formulation effectively reduces fever and alleviates pain and inflammation (swelling and redness) in infants and children. Administer PediaTemp Oral Suspension to your child precisely as directed, ideally at the same time each day. It may be given with or without food; however, post-meal administration may lessen stomach upset. If your child vomits within 30 minutes, repeat the dose. Never exceed the recommended dosage; doing so may lead to adverse reactions. Mild side effects such as nausea, vomiting, abdominal pain, indigestion, and diarrhea may occur. These are usually transient and self-limiting. However, persistent or troublesome side effects warrant immediate consultation with your child's physician. Prior to administering PediaTemp Oral Suspension, inform your doctor of any known allergies, pre-existing heart conditions, congenital defects, liver, kidney, lung issues, or bleeding disorders. This information is crucial for accurate dosing and optimal treatment planning.
Primary Ingredients of Sarispas M Oral Suspension
No information provided. Unable to rephrase.
Uses of Sarispas M Oral Suspension
Alleviating pain and reducing fever.
Major Benefits of Sarispas M Oral Suspension:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Consult the product label for complete instructions prior to ingestion. Use a measuring device for accurate dispensing and consume orally. Ensure thorough shaking before each use. Sarispas M Oral Suspension can be ingested with or without food; however, consistent daily timing is recommended.
Common Side effects of Sarispas M Oral Suspension:
- Nausea
- Vomiting
- Abdominal pain
- Heartburn
- Diarrhea
- Dizziness
How to use Sarispas M Oral Suspension:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Consult the product label for complete instructions prior to use. Employ a measuring cup for accurate oral administration. Ensure thorough shaking before each dose. Sarispas M Oral Suspension can be ingested with or without food; however, consistent timing is recommended for optimal results.
How Sarispas M Oral Suspension works:
Sarispas M Oral Suspension, a combination medication, utilizes mefenamic acid and paracetamol, both non-steroidal anti-inflammatory drugs (NSAIDs), to alleviate symptoms. Its mechanism involves inhibiting the production of inflammatory mediators responsible for fever, pain, and the characteristic inflammation of redness and swelling.
SAFETY ADVICE
KidneyCAUTION
Patients with kidney impairment should use Sarispas M Oral Suspension cautiously, potentially requiring dosage modification. Physician consultation is advised. Sarispas M Oral Suspension is unsuitable for children suffering from severe kidney disease.
LiverSAFE IF PRESCRIBED
Sarispas M Oral Suspension presents no known safety concerns for individuals with hepatic impairment; dosage modification is unnecessary. However, routine liver function tests (LFTs) are advised for pediatric patients undergoing prolonged Sarispas M Oral Suspension therapy.
What if you forget to take Sarispas M Oral Suspension :
Remain calm. Administer the forgotten dose immediately upon recollection. Omit the missed dose, however, if the next scheduled dose is imminent, or if your pediatrician has advised against replacing missed doses. Avoid doubling the dose and adhere strictly to the recommended dosage regimen.
Facts to Know About Sarispas M Oral Suspension
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
